Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medical Devices Average | - - | - - | - - | 18,827.69 | 909.04 | 86.07 | 1,806.88 | 11.19 | 0.03 | 7.1602 | 0.74 | 49.2713 | -91.5995 | -0.90 | -2.67 | 423.7783 | - - | ||
Maximum | - - | - - | - - | 175,448.00 | 5,435.00 | 788.00 | 17,254.00 | 239.00 | 0.52 | 191.2553 | 13.46 | 100.0000 | 62.8500 | 6.26 | 7.65 | 2,103.5900 | - - | ||
Minimum | - - | - - | - - | 4.00 | 0.00 | -252.00 | -2,869.00 | -138.00 | 0.00 | -252.6195 | -2.66 | -280.7600 | -2,420.5000 | -16.57 | -50.58 | 0.0000 | - - | ||
Eli Lilly and Company LLY | 904.97 | -1.21 -0.13% | 1,435 vs. 3,199 | 860,107.00 | 8,768.00 | 2,242.00 | 179.00 | 12,553.00 | 2.4900 | 76.3636 | 0.17 | 82.50 | 25.58 | 17.51 | 3.51 | 67.75 | 950.00 | ||
AbbVie Inc. ABBV | 192.94 | -0.51 -0.26% | 2,474 vs. 5,220 | 340,797.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.87 | 66.84 | 11.12 | 17.10 | 0.92 | 72.29 | 1,766.00 | ||
Abbott Laboratories ABT | 114.88 | -3.25 -2.75% | 4,535 vs. 6,122 | 199,879.00 | 9,964.00 | 1,225.00 | 627.00 | 38,011.00 | 0.7100 | 39.6679 | 0.49 | 55.64 | 12.29 | 3.16 | 1.69 | 94.54 | 1,739.00 | ||
Johnson & Johnson JNJ | 166.15 | -0.92 -0.55% | 3,381 vs. 6,838 | 399,962.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.76 | 68.78 | 15.22 | 4.65 | 1.89 | 84.48 | 2,407.00 | ||
Bristol-Myers Squibb Company BMY | 49.74 | 0.25 0.51% | 5,492 vs. 14,238 | 100,842.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 1.13 | 75.29 | -100.39 | -72.23 | -12.03 | 91.90 | 2,027.00 |